The Pep FilesSeptember 2026Back to PepShop
X-Labs logo
X-LABS
PRECISION PEPTIDES. PREMIUM PERFORMANCE.

THE PEP FILES

September 2026 Data Released by RealFit Group & X-Labs

RealFit round logo
Sample Research View
Anonymised participant data only
R
POWERED BYREALFITGROUP ACCOUNTING
♙
Active Participants34887 more than August (+33.3%)
⚖
Avg Weight Loss (12 Weeks)16.18 kgOverall recorded average
♧
Leading Recorded ProductX-Labs RETASeptember ranking
▣
I Love 2 Lose Engagement+34%Registered shoppers actively tracking with Captains
★
Leading Brand OverallX-LabsSeptember preference ranking

Leading Peptide Products — September

Observed most-bought/used ranking from the September research summary. Ranking does not establish comparative medical efficacy.

1
X-Labs Retatrutide (RETA)Leading September reported product
2
X-Labs RETA / Tirzepatide (TIRZ) ComboSeptember recorded rank 2
3
HD Labs Retatrutide (RETA)September recorded rank 3
4
X-Labs Tirzepatide (TIRZ)September recorded rank 4
5
Noventra Retatrutide (RETA)September recorded rank 5
Participant Growth — July to September 2026
July195

Reported research participants

August261

Reported research participants

September348

+87 vs August; +33.3% month on month

12-week average weight loss16.18 kg

August: 16.27 kg · July: 15.90 kg. All periods compare recorded 12-week outcomes.

The reported average weight loss is based on a standard 12-week observation period, not a claim about every participant. Brand and product rankings are observational, not controlled comparisons.
September Research Snapshot
Active participants348

Increase from 261 in August.

Men participating+11%

Reported increase during September; the baseline was not specified.

I Love 2 Lose activity+34%

Increase in PepShop shoppers registered on the app and actively tracking with their Captains.

Leading reported productX-Labs RETA

Top September product ranking.

More than the number on the scale: PepShop's I Love 2 Lose app helps participating shoppers and their Captains record and monitor their journeys consistently, supporting structured tracking and accountability.

Research transparency: All data is anonymised and observational. These figures are internally reported and have not been independently validated. Results vary; this report is not clinical evidence of efficacy or safety and is not medical advice.
September 2026
active research cohort

78% Shared Five Common Characteristics

According to PepShop's September research summary, 78% of active research participants had all five of these characteristics in common during their weight-loss journeys:

  1. Used Retatrutide (RETA), Tirzepatide (TIRZ) or a RETA/TIRZ combination, regardless of preferred brand.
  2. Owned and used a BNETA Smart Scale for body-measurement tracking.
  3. Followed a protein-rich diet.
  4. Used the I Love 2 Lose app and selected an experienced Captain for support, guidance and accountability.
  5. Attended Coach Helené's classes or similar online classes at least three times per week.

Research interpretation: This is a reported association in an observational group, not evidence that these factors—or the peptides named—caused the recorded weight loss, nor proof of treatment safety or efficacy. No individual participant data is displayed.